Clinical Trial Update: Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing recombinant human thrombopoietin (rhTPO) for managing immune thrombocytopenia in pregnancy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Recombinant human thrombopoietin (rhTPO) (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia, Pregnancy | Phase 3 | Status: UNKNOWN